Taken together, these data indicate that de novo expression of abnormal ECM components in the TRS of iCCA is functionally relevant to promote motility and CSC features of malignant cholangiocytes, and in this respect, OPN behaves as a key determinant of the enhanced fibrogenesis featuring MetS-associated iCCA. The gene discussed is SPP1; the disease is metabolic syndrome.